Duan Z - Search Results

1

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.

Lietz CE, Garbutt C, Barry WT, Deshpande V, Chen YL, Lozano-Calderon SA, Wang Y, Lawney B, Ebb D, Cote GM, Duan Z, Hornicek FJ, Choy E, Petur Nielsen G, Haibe-Kains B, Quackenbush J, Spentzos D. Lietz CE, et al. Among authors: duan z. Sci Rep. 2020 Mar 10;10(1):4409. doi: 10.1038/s41598-020-61236-3. Sci Rep. 2020. PMID: 32157112 Free PMC article.

2

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9. doi: 10.1007/s00280-008-0785-8. Epub 2008 Jun 28. Cancer Chemother Pharmacol. 2009. PMID: 18587580 Free PMC article.

3

Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.

Duan Z, Weinstein EJ, Ji D, Ames RY, Choy E, Mankin H, Hornicek FJ. Duan Z, et al. Mol Cancer Ther. 2008 Aug;7(8):2377-85. doi: 10.1158/1535-7163.MCT-08-0316. Epub 2008 Aug 7. Mol Cancer Ther. 2008. PMID: 18687998 Free PMC article.

4

Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.

Duan Z, Choy E, Jimeno JM, Cuevas Cdel M, Mankin HJ, Hornicek FJ. Duan Z, et al. Cancer Chemother Pharmacol. 2009 May;63(6):1121-9. doi: 10.1007/s00280-008-0843-2. Epub 2008 Oct 1. Cancer Chemother Pharmacol. 2009. PMID: 18828019

5

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Yang C, Yang S, Wood KB, Hornicek FJ, Schwab JH, Fondren G, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Apoptosis. 2009 Jan;14(1):124-33. doi: 10.1007/s10495-008-0282-x. Apoptosis. 2009. PMID: 19052873

6

RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.

Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Cancer Chemother Pharmacol. 2009 Aug;64(3):607-14. doi: 10.1007/s00280-008-0912-6. Epub 2009 Jan 6. Cancer Chemother Pharmacol. 2009. PMID: 19125251

7

Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.

Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, Nielsen P, Iafrate J, Delaney T, Yoon S, Choy E, Harmon D, Raskin K, Yang C, Mankin H, Springfield D, Hornicek F, Duan Z. Schwab J, et al. Among authors: duan z. Anticancer Res. 2009 Jun;29(6):1867-71. Anticancer Res. 2009. PMID: 19528441 Free article.

8

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Duan Z, et al. Mol Cancer Ther. 2009 Aug;8(8):2122-30. doi: 10.1158/1535-7163.MCT-09-0115. Epub 2009 Jul 28. Mol Cancer Ther. 2009. PMID: 19638450 Free PMC article.

9

A novel target for treatment of chordoma: signal transducers and activators of transcription 3.

Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, Nielsen GP, Choy E, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Mol Cancer Ther. 2009 Sep;8(9):2597-605. doi: 10.1158/1535-7163.MCT-09-0504. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723879

10

ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Duan Z, et al. PLoS One. 2009 Sep 9;4(9):e6967. doi: 10.1371/journal.pone.0006967. PLoS One. 2009. PMID: 19742314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,045 results

Search Page

Filters